iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sets New 1-Year High – What’s Next?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $95.71 and last traded at $95.35, with a volume of 368115 shares changing hands. The stock had previously closed at $94.12.

iShares U.S. Pharmaceuticals ETF Price Performance

The firm has a market capitalization of $1.03 billion, a PE ratio of 17.75 and a beta of 0.50. The stock has a 50-day moving average price of $89.90 and a 200-day moving average price of $87.93.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Hedge funds and other institutional investors have recently bought and sold shares of the business. EFG International AG acquired a new position in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth $38,000. O Shaughnessy Asset Management LLC increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 35.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after acquiring an additional 120 shares during the last quarter. Assetmark Inc. increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 203.9% in the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after acquiring an additional 312 shares during the last quarter. Blueline Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $41,000. Finally, Accent Capital Management LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $42,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.